Treatment of malignant disease in AIDS patients.
Volberding
P
P
AIDS Activities Division, San Francisco General Hospital, University of California 94110.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use; D008228:Lymphoma, Non-Hodgkin / Q000209:etiology / Q000628:therapy; D009369:Neoplasms / Q000209:etiology / Q000628:therapy*; D009894:Opportunistic Infections / Q000150:complications / Q000517:prevention & control; D012514:Sarcoma, Kaposi / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D015215:Zidovudine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D007370:Interferon Type I; D015215:Zidovudine